Skip to Content

HCA Healthcare (HCA US)

HCA US$499.05

20 minute delayed

Today ▼ -0.32%
1 year return ▲ 5.44%
Volume 324,703
Div yield 0.61%
PE ratio 16.55
52 week range
354.00 556.40

14 days free access

Join Market Matters and get full access to all our Opinion + Action

Learn more

Performance

Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.

Share price activity

Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
Last (Price)
499.05
Change
▼ -1.61 (-0.32)
Bid / Ask
0.00 - 0.00
Volume
324,703
Turnover
147,570,288
Open
504.85
Day Range
497.00 - 506.00
VWAP
499.35
Prev Close
500.66
Last Trade
15/11 7:00pm
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
Ratios
Currency (Price/reporting): USD/USD
Exchange Rate: 1.0000
Price, volume and trading statistics for the security, sourced from Morningstar.
Price - closing or last bid 504.42
Price - 12 month high 556.40
Price - 12 month low 354.00
Pricing date 10 NOV 2026
Volume - avg. trading volume for the last ten days 1.73
Market capitalization 105,707.96
12 Month High price date 12 MAR 2026
12 Month Low price date 14 JUL 2026
Volume - avg. trading volume for the last 3 months 1.36
Price - 1 Day % Change -0.09%
Price - 13 week price percent change 21.83%
Price - 26 week price percent change 15.91%
Price - 5 Day % Change 8.98%
Price - 52 week price percent change 9.82%
Price - YTD price percent change 6.58%
Price % Change Month To Date 11.82%
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
EPS excluding extraordinary items - most recent fiscal year 28.330
EPS excluding extraordinary items - trailing 12 month 30.150
EPS Normalized - most recent fiscal year 28.210
Revenue/share - most recent fiscal year 315.664
Revenue/share - trailing 12 month 350.876
Book value per share - most recent fiscal year -26.834
Book value per share - most recent quarter -38.301
Book value (tangible) per share - most recent fiscal year -58.164
Book value (tangible) per share - most recent quarter -74.914
Cash per share - most recent fiscal year 4.630
Cash per share - most recent quarter 4.306
Cash Flow per share - most recent fiscal year 51.016
Cash Flow per share - trailing 12 month 50.036
Dividend per share - most recent fiscal year 2.880
Dividends per share - trailing 12 month 3.060
EBITD per share - trailing 12 month 70.995
EPS Basic excluding extraordinary items - most recent fiscal year 28.700
EPS Basic excluding extraordinary items - trailing 12 month 30.540
EPS including extraordinary items - most recent fiscal year 28.700
EPS including extraordinary items - trailing 12 month 30.540
Free Cash Flow per share - trailing 12 month 26.870
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
P/E excluding extraordinary items, most recent fiscal year 16.78
P/E Normalized, most recent fiscal year 16.88
Price to sales - most recent fiscal year 1.44
Price to Tangible Book - most fiscal year —
Price to Free Cash Flow per Share - most recent fiscal year 18.83
Price to Cash Flow per share - trailing 12 month 10.11
Price to Book - most recent fiscal year —
P/E excluding extraordinary items high, trailing 12 months 19.95
P/E excluding extraordinary items low, trailing 12 months 12.44
Net Debt, LFI 51,518.00
Net Debt, LFY 47,657.00
Dividend Yield - 5 Year Average 0.77%
Dividend Yield - indicated annual dividend divided by closing price 0.61%
Current Dividend Yield - Common Stock Primary Issue, LTM 0.60%
Cash flow, liquidity and leverage measures, sourced from Morningstar.
Free Cash Flow - most recent fiscal year 7,274.00
LT debt/equity - most recent fiscal year —
Payout ratio - most recent fiscal year 10.17%
Total debt/total equity - most recent fiscal year —
LT debt/equity - most recent quarter —
Total debt/total equity - most recent quarter —
Free Cash Flow - trailing 12 month 6,027.00
Payout ratio - trailing 12 month 10.14%
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
Revenue - most recent fiscal year 75,600.00
Revenue - trailing 12 month 78,701.00
EBITD - most recent fiscal year 15,603.00
EBITD - trailing 12 month 15,924.00
Earnings before taxes - most recent fiscal year 9,832.00
Earnings before taxes - trailing 12 month 9,823.00
Net Income available to common - most recent fiscal year 6,784.00
Net Income available to common - trailing 12 months 6,776.00
Earnings before taxes Normalized - most recent fiscal year 10,159.00
Net Income Available to Common, Normalized - most recent fiscal year —
Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM 29.98
Profitability margins for the most recent fiscal year, sourced from Morningstar.
Net Profit Margin % - 1st historical fiscal year 10.29%
Net Profit Margin % - trailing 12 month 9.91%
Operating margin - 1st historical fiscal year 15.83%
Operating margin - trailing 12 month 15.31%
Pretax margin - trailing 12 month 12.48%
Pretax margin - 1st historical fiscal year 13.01%
Operating Margin - 5 year average 15.42%
Pretax Margin - 5 year average 13.58%
Free Operating Cash Flow/Revenue, 5 Year Average 8.72%
Free Operating Cash Flow/Revenue, TTM 7.66%
Net Profit Margin - 5 year average 10.72%
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
Return on average assets - most recent fiscal year 13.00%
Return on average assets - trailing 12 month 12.64%
Return on average equity - most recent fiscal year —
Return on average equity - trailing 12 month —
Return on average assets - 5 year average 12.78%
Return on average equity - 5 year average —
Net Income/employee - most recent fiscal year 33,834.78
Revenue/employee - most recent fiscal year 328,695.65
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
Revenue growth rate, 5 year 7.97%
EPS growth rate, 5 year 20.98%
Growth rate% - dividend, 3 year 8.74%
Revenue/share (5 yr growth) 16.05%
Growth rate% - Revenue, 3 year 7.87%
Growth rate% - EPS, 3 year 13.94%
Book value per share growth rate, 5 year —
Capital Spending growth rate, 5 year 11.76%
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR 9.89%
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.

Financial forecast (USD, millions except per share)

Actuals Estimates
2025 2026202720282029
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.

Financials (USD, millions)

Period end: DEC 21DEC 22DEC 23DEC 24DEC 25
Fiscal year: 20212022202320242025
Period length: 12 months12 months12 months12 months12 months
Displays all company announcements released by the company to the exchange, sourced from Morningstar.

Announcements

Announcements are available for ASX-listed companies only.

Opinion

Action

Business Summary

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

WATCH Performance update for March, stocks that drove returns & our current positioning Recorded Tuesday 9th April
Back to top